Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic properties of two long-acting insulin analogues compared with NPH insulin
2004-003887-31Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in insulin deficiency, diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) comparing Insulin glargine, Insulin detemir and NPH human insulin (3 arms). Primary endpoint: Glucose infusion rate (GIR). Started Nov 2004; status: completed.
02
Drugs
insulin glargineinsulin detemirinsulin isophane
03
Conditions
insulin deficiencydiabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-003887-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003887-31.